| Date | Form | Description | Docs | XBRL | Pages |
| 01/29/15 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
15 | |
| 01/29/15 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
101 |
| 04/16/14 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
41 | |
| 01/17/14 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
|
6 |
| 01/16/14 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
111 | |
| 08/27/13 | ARS | Annual report to security holders |
|
108 | |
| 01/29/13 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
|
244 |
| 01/30/12 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
|
94 |
| 02/14/11 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
102 | |
| 01/31/11 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
4 |
Latest News & Events
Anixa Biosciences Establishes Cancer Business Advisory Board
Read More...Anixa Biosciences to Participate in September Investor Conferences
Read More...Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial
Read More...